These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16000281)

  • 21. Cerebral blood flow in temporal lobe epilepsy: a partial volume correction study.
    Giovacchini G; Bonwetsch R; Herscovitch P; Carson RE; Theodore WH
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2066-72. PubMed ID: 17768621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study.
    Merlet I; Ostrowsky K; Costes N; Ryvlin P; Isnard J; Faillenot I; Lavenne F; Dufournel D; Le Bars D; Mauguière F
    Brain; 2004 Apr; 127(Pt 4):900-13. PubMed ID: 14985263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A positron emission tomography study of 5-hydroxytryptamine-1A receptors in Alzheimer disease.
    Lanctôt KL; Hussey DF; Herrmann N; Black SE; Rusjan PM; Wilson AA; Houle S; Kozloff N; Verhoeff NP; Kapur S
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):888-98. PubMed ID: 17567932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy.
    Savic I; Lindström P; Gulyás B; Halldin C; Andrée B; Farde L
    Neurology; 2004 Apr; 62(8):1343-51. PubMed ID: 15111672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced serotonin type 1A receptor binding in panic disorder.
    Neumeister A; Bain E; Nugent AC; Carson RE; Bonne O; Luckenbaugh DA; Eckelman W; Herscovitch P; Charney DS; Drevets WC
    J Neurosci; 2004 Jan; 24(3):589-91. PubMed ID: 14736842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-Mefway PET imaging of serotonin 1A receptors in humans: a comparison with 18F-FCWAY.
    Choi JY; Lyoo CH; Kim JS; Kim KM; Kang JH; Choi SH; Kim JJ; Ryu YH
    PLoS One; 2015; 10(4):e0121342. PubMed ID: 25830772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of optimal acquisition time of [(18)F]FCWAY PET for imaging serotonin 1A receptors in the healthy male subjects.
    Choi JY; Lee M; Jeon TJ; Choi SH; Choi YJ; Lee YK; Kim JJ; Ryu YH
    Appl Radiat Isot; 2014 Jul; 89():141-5. PubMed ID: 24631746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [
    Finnema SJ; Toyonaga T; Detyniecki K; Chen MK; Dias M; Wang Q; Lin SF; Naganawa M; Gallezot JD; Lu Y; Nabulsi NB; Huang Y; Spencer DD; Carson RE
    Epilepsia; 2020 Oct; 61(10):2183-2193. PubMed ID: 32944949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors.
    Hillmer AT; Wooten DW; Bajwa AK; Higgins AT; Lao PJ; Betthauser TJ; Barnhart TE; Rowley HA; Stone CK; Johnson SC; Mukherjee J; Christian BT
    J Nucl Med; 2014 Dec; 55(12):1973-9. PubMed ID: 25453045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate.
    Saigal N; Pichika R; Easwaramoorthy B; Collins D; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2006 Oct; 47(10):1697-706. PubMed ID: 17015907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy.
    Szelies B; Weber-Luxenburger G; Pawlik G; Kessler J; Holthoff V; Mielke R; Herholz K; Bauer B; Wienhard K; Heiss WD
    Neuroimage; 1996 Apr; 3(2):109-18. PubMed ID: 9345482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of temporal lobe glucose metabolism with the Wada memory test.
    Hong SB; Roh SY; Kim SE; Seo DW
    Epilepsia; 2000 Dec; 41(12):1554-9. PubMed ID: 11114213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential 123I-iododexetimide scans in temporal lobe epilepsy: comparison with neuroimaging scans (MR imaging and 18F-FDG PET imaging).
    Mohamed A; Eberl S; Fulham MJ; Kassiou M; Zaman A; Henderson D; Beveridge S; Constable C; Lo SK
    Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):180-5. PubMed ID: 15449046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Auras and clinical features in temporal lobe epilepsy: a new approach on the basis of voxel-based morphometry.
    Santana MT; Jackowski AP; da Silva HH; Caboclo LO; Centeno RS; Bressan RA; Carrete H; Yacubian EM
    Epilepsy Res; 2010 May; 89(2-3):327-38. PubMed ID: 20223639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy.
    Vivash L; Gregoire MC; Lau EW; Ware RE; Binns D; Roselt P; Bouilleret V; Myers DE; Cook MJ; Hicks RJ; O'Brien TJ
    J Nucl Med; 2013 Aug; 54(8):1270-7. PubMed ID: 23857513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo hippocampal glucose metabolism in mesial temporal lobe epilepsy.
    Knowlton RC; Laxer KD; Klein G; Sawrie S; Ende G; Hawkins RA; Aassar OS; Soohoo K; Wong S; Barbaro N
    Neurology; 2001 Oct; 57(7):1184-90. PubMed ID: 11591833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of opioid receptor availability following spontaneous epileptic seizures: correction of [11C]diprenorphine PET data for the partial-volume effect.
    McGinnity CJ; Shidahara M; Feldmann M; Keihaninejad S; Riaño Barros DA; Gousias IS; Duncan JS; Brooks DJ; Heckemann RA; Turkheimer FE; Hammers A; Koepp MJ
    Neuroimage; 2013 Oct; 79():72-80. PubMed ID: 23597934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlations of interictal FDG-PET metabolism and ictal SPECT perfusion changes in human temporal lobe epilepsy with hippocampal sclerosis.
    Nelissen N; Van Paesschen W; Baete K; Van Laere K; Palmini A; Van Billoen H; Dupont P
    Neuroimage; 2006 Aug; 32(2):684-95. PubMed ID: 16762567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of 5-HT1A receptor radioligands to determine receptor density and changes in endogenous 5-HT.
    Jagoda EM; Lang L; Tokugawa J; Simmons A; Ma Y; Contoreggi C; Kiesewetter D; Eckelman WC
    Synapse; 2006 May; 59(6):330-41. PubMed ID: 16440292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-[11C] methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy.
    Natsume J; Kumakura Y; Bernasconi N; Soucy JP; Nakai A; Rosa P; Fedi M; Dubeau F; Andermann F; Lisbona R; Bernasconi A; Diksic M
    Neurology; 2003 Mar; 60(5):756-61. PubMed ID: 12629229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.